Sandra Fyfe is a freelance writer for Contemporary OB/GYN.
TTCRF Greatly Improves SUI, Sexual Dysfunction, and Genital Appearance
May 13th 2021A new study led by Sejal Ajmera Desai, MD, MBBS, a consultant ob/gyn at the Indian Academy of Vaginal Aesthetics in Mumbai, India, found that women who received transcutaneous temperature-controlled radiofrequency treatment (TTCRF) saw substantial improvement in stress urinary incontinence (SUI), sexual dysfunction (SD), and female genital appearance. The most significant takeaway from this study for providers, according to study supervisor George Kroumpouzos, MD, PhD, FAAD, is that TTCRF is safe and effective.
Read More
Lower levels of testing and higher positivity rates, higher rates of dangerous drug combination use, and increases in fatal and non-fatal overdoses during the coronavirus disease 2019 (COVID-19) pandemic reveal a need for more resources to address the opioid epidemic in the United States.
Read More
How Sex and Gender Disparities Affect Women during the COVID-19 Pandemic
March 2nd 2021Diverse Voices: COVID-19 and the Health of Women, a virtual speaker series run by the NIH Office of Research on Women’s Health (ORWH), presented compiled research on sex and gender disparities during the COVID-19 pandemic. In addition to identifying issues of concern, the webinar offered actions to improve women’s health despite sex and gender disadvantages.
Read More
More Research and Screening for STIs Needed to Improve Worldwide Maternal and Neonatal Health
February 26th 2021A narrative review identified gaps in knowledge and considerations for informing sexually transmitted infection (STI) screening guidelines and treatment to improve the health of pregnant women and children.
Read More
Laparoscopy better than imaging for accurate staging in locally advanced cervical cancer
January 11th 2021While no difference was shown in disease-free survival rates between surgical and non-surgical staging methods, laparoscopy benefits patients with International Federation of Gynecology and Obstetrics (FIGO) stage IIB cervical cancer. Surgical staging also has a cancer-specific survival benefit, according to a study published in the International Journal of Gynecological Cancers.
Read More
Reversing endometrial hyperplasia with levonorgestrel-intrauterine system: a Cochrane review
December 8th 2020In the largest meta-analysis study to date, researchers find that a levonorgestrel-intrauterine system (LNG-IUS) used for 3 to 6 months is likely more effective than non‐intrauterine progestogens for reversing endometrial hyperplasia (EH).
Read More